scholarly journals Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound

2015 ◽  
Vol 4 (3) ◽  
pp. 219 ◽  
Author(s):  
ManoopS Bhutani ◽  
Mehmet Bektas ◽  
SomashekarG Krishna ◽  
WilliamA Ross ◽  
Brian Weston ◽  
...  
2007 ◽  
Vol 65 (5) ◽  
pp. AB308 ◽  
Author(s):  
Marcia I. Canto ◽  
Samuel S. Giday ◽  
Jonathan M. Buscaglia ◽  
Sergey V. Kantsevoy ◽  
Christopher L. Wolfgang ◽  
...  

Pancreas ◽  
2016 ◽  
Vol 45 (2) ◽  
pp. 265-268 ◽  
Author(s):  
Pietro Fusaroli ◽  
Marta Serrani ◽  
Roberto De Giorgio ◽  
Maria Cristina D’Ercole ◽  
Liza Ceroni ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Giovanni Morana ◽  
Pierluigi Ciet ◽  
Silvia Venturini

AbstractCystic pancreatic lesions (CPLs) are frequently casual findings in radiological examinations performed for other reasons in patients with unrelated symptoms. As they require different management according to their histological nature, differential diagnosis is essential. Radiologist plays a key role in the diagnosis and management of these lesions as imaging is able to correctly characterize most of them and thus address to a correct management. The first step for a correct characterization is to look for a communication between the CPLs and the main pancreatic duct, and then, it is essential to evaluate the morphology of the lesions. Age, sex and a history of previous pancreatic pathologies are important information to be used in the differential diagnosis. As some CPLs with different pathologic backgrounds can show the same morphological findings, differential diagnosis can be difficult, and thus, the final diagnosis can require other techniques, such as endoscopic ultrasound, endoscopic ultrasound-fine needle aspiration and endoscopic ultrasound-through the needle biopsy, and multidisciplinary management is important for a correct management.


2019 ◽  
Vol 07 (02) ◽  
pp. E186-E188
Author(s):  
Daniel Gaballa ◽  
Catherine Abendroth ◽  
Matthew Moyer

Abstract Background and study aims Endoscopic ultrasound (EUS)-guided chemoablation with ethanol lavage, followed by infusion with paclitaxel, has been found to be effective for treatment of mucinous pancreatic cysts. However, there are notable adverse events (AEs) associated with ethanol and its undesirable inflammatory effects on local tissue and vessels. The recent ChARM trial demonstrated that removing ethanol from the cyst ablation process resulted in equivalent efficacy while significantly reducing associated AEs. Encouraged by these results, we speculated that alcohol-free chemoablation can be applied to treatment of solid tumors, as described in our case with a patient with severe and symptomatic recurrent hypoglycemia in the setting of multifocal insulinomas. As a result, the patient saw a significant reduction in symptoms. EUS-guided alcohol-free chemoablation may represent a new alternative to previously established therapies that will ultimately reduce risk of AEs.


2018 ◽  
Vol 46 (5) ◽  
pp. 395-399 ◽  
Author(s):  
Ivan Chebib ◽  
Emily Albanese ◽  
Aristana Scourtas ◽  
Martha B. Pitman

Sign in / Sign up

Export Citation Format

Share Document